US Food and Drug Administration Action on Menthol Cigarettes and Flavored Cigars - A Pivotal Moment for Health Equity

Andrea C. Villanti, Kymberle Sterling, Shyanika W. Rose

Research output: Contribution to journalComment/debate

13 Scopus citations
Original languageEnglish
Article numbere2217150
JournalJAMA network open
Volume5
Issue number6
DOIs
StatePublished - Jun 6 2022

Funding

Conflict of Interest Disclosures: Dr Villanti reported receiving grants from the National Institutes of Health during the conduct of the study. Dr Rose reported receiving grants from the National Cancer Institute and Truth Initiative during the conduct of the study and personal fees from the US Food and Drug Administration via Versar (honoraria for review panel) outside the submitted work. No other disclosures were reported. Funding/Support: The authors receive funding from the National Institutes of Health and Food and Drug Administration under award numbers R21DA051943 (to Dr Villanti), R01DA051001 (to Dr Villanti), R01CA228906 (to Dr Sterling), and R01CA251478 (to Dr Rose).

FundersFunder number
Truth Initiative
U.S. Food and Drug Administration
National Institute on Drug AbuseR21DA051943, R01DA051001
National Institutes of Health and Food and Drug AdministrationR21DA051943, R01CA228906, R01DA051001, R01CA251478
National Childhood Cancer Registry – National Cancer InstituteR01CA228906, R01CA251478

    ASJC Scopus subject areas

    • General Medicine

    Fingerprint

    Dive into the research topics of 'US Food and Drug Administration Action on Menthol Cigarettes and Flavored Cigars - A Pivotal Moment for Health Equity'. Together they form a unique fingerprint.

    Cite this